Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1 study found for:    18177818 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Recruiting Investigation of 68Ga-DOTATATE, as a PET Imaging Agent in Neuroendocrine Tumor Patients
Condition: Neuroendocrine Carcinoma
Intervention: Drug: 68Ga-DOTATATE

Study has passed its completion date and status has not been verified in more than two years.